1.3.8.7: medium-chain acyl-CoA dehydrogenase
This is an abbreviated version!
For detailed information about medium-chain acyl-CoA dehydrogenase, go to the full flat file.
Word Map on EC 1.3.8.7
-
1.3.8.7
-
carnitine
-
beta-oxidation
-
infant
-
acylcarnitines
-
children
-
peroxisome
-
urine
-
mcadd
-
inborn
-
error
-
proliferator-activated
-
hypoglycemia
-
acidurias
-
triglyceride
-
flavoproteins
-
fad
-
phenylketonuria
-
octanoylcarnitine
-
palmitoyltransferase
-
acidemia
-
glutaric
-
octanoyl-coa
-
octanoic
-
hypoketotic
-
nbs
-
vlcad
-
decompensation
-
coma
-
pparalpha
-
methylmalonic
-
isovaleric
-
very-long-chain
-
decanoic
-
isovaleryl-coa
-
syrup
-
reye-like
-
lethargy
-
3-hydroxyacyl-coa
-
maple
-
homocystinuria
-
guthrie
-
biotinidase
-
acadvl
-
3-methylcrotonyl-coa
-
phenylpropionic
-
butyryl-coa
-
alpha-proton
-
medicine
-
analysis
- 1.3.8.7
- carnitine
-
beta-oxidation
- infant
- acylcarnitines
- children
- peroxisome
- urine
-
mcadd
-
inborn
- error
-
proliferator-activated
- hypoglycemia
- acidurias
- triglyceride
- flavoproteins
- fad
- phenylketonuria
- octanoylcarnitine
- palmitoyltransferase
- acidemia
-
glutaric
- octanoyl-coa
-
octanoic
-
hypoketotic
- nbs
- vlcad
- decompensation
- coma
- pparalpha
-
methylmalonic
-
isovaleric
-
very-long-chain
-
decanoic
- isovaleryl-coa
- syrup
-
reye-like
- lethargy
- 3-hydroxyacyl-coa
-
maple
- homocystinuria
-
guthrie
- biotinidase
- acadvl
- 3-methylcrotonyl-coa
-
phenylpropionic
- butyryl-coa
-
alpha-proton
- medicine
- analysis
Reaction
Synonyms
ACAD-9, ACADM, ACD, acyl CoA dehydrogenase, acyl coenzyme A dehydrogenase, acyl dehydrogenase, acyl-CoA dehydrogenase, acyl-CoA dehydrogenase-9, dehydrogenase, acyl coenzyme A, EC 1.3.2.2, EC 1.3.99.3, FadE, fatty acyl coenzyme A dehydrogenase, fatty-acyl-CoA dehydrogenase, general ACAD, general acyl CoA dehydrogenase, LCAD, LipB, MCAD, MCADH, medium chain acyl-CoA dehydrogenase, medium chain-specific acyl-CoA oxidase, medium-chain acyl CoA dehydrogenase, medium-chain acyl-CoA dehydrogenase, medium-chain acyl-coenzyme A dehydrogenase, medium-chain coenzyme A dehydrogenase, pMCAD, PP_1893, PP_2039, PP_2048, PP_2437
ECTree
Advanced search results
Engineering
Engineering on EC 1.3.8.7 - medium-chain acyl-CoA dehydrogenase
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
A1010C
-
genotype, the naturally occuring mutation is involved in medium-chain acyl-CoA dehydrogenase deficiency
A151T
-
the mutation is involved in medium chain acyl-CoA dehydrogenase deficiency
A31P
A52V
mutation identified in a newborn. Mutatio lowers the temperature threshold at which loss-of-function occurs
A533C
-
genotype, the naturally occuring mutation is involved in medium-chain acyl-CoA dehydrogenase deficiency
A985G
D266G
mutation identified in a newborn. Mutatio lowers the temperature threshold at which loss-of-function occurs
D79X
-
the mutation is involved in medium chain acyl-CoA dehydrogenase deficiency
E18K
E376G
-
the rate of dehydrogenation is lowered by approximately 5 orders of magnitude
E376Q
G127A
-
genotype, the naturally occuring mutation is involved in medium-chain acyl-CoA dehydrogenase deficiency, not clearly associated with a clinical phenotype
G170R
-
the mutation is involved in medium chain acyl-CoA dehydrogenase deficiency
G285R
-
the mutation is involved in medium chain acyl-CoA dehydrogenase deficiency
G799A
-
genotype, the naturally occuring mutation is involved in medium-chain acyl-CoA dehydrogenase deficiency
K304E
K329E
L59F
-
the mutation is involved in medium chain acyl-CoA dehydrogenase deficiency
L73DELTA
-
the mutation is involved in medium chain acyl-CoA dehydrogenase deficiency
N169D
-
the mutation is involved in medium chain acyl-CoA dehydrogenase deficiency
N396Y
-
involved in MCAD deficiency with a MCAD activity of 11.2% compared to the wild type enzyme, in combination with the deletion mutation DELTA449-CTGA-452
P128X
-
the mutation is involved in medium chain acyl-CoA dehydrogenase deficiency
Q20R
-
the mutation is involved in medium chain acyl-CoA dehydrogenase deficiency
R123K
-
the mutation is involved in medium chain acyl-CoA dehydrogenase deficiency
R206C
mutation identified in a newborn. Mutatio lowers the temperature threshold at which loss-of-function occurs
R256S
-
the mutation is involved in medium chain acyl-CoA dehydrogenase deficiency
R334K
mutation identified in a newborn. Mutatio lowers the temperature threshold at which loss-of-function occurs
R413S
mutation identified in a newborn. Mutatio lowers the temperature threshold at which loss-of-function occurs
T1229G
-
genotype, the naturally occuring mutation is involved in medium-chain acyl-CoA dehydrogenase deficiency
T168A
-
thermostability is markedly decreased, 80% lowered activity in ferricinum assay
T199C
-
genotype, the naturally occuring mutation is involved in medium-chain acyl-CoA dehydrogenase deficiency, not clearly associated with a clinical phenotype
T255E
-
same activity with octanoyl-CoA as wild-type, activity/chain length profile is, however, narrower
T255E/E376G
-
chimeric medium-long chain acyl-CoA dehydrogenase, has 20% of the activity of medium-chain acyl-CoA dehydrogenase and 25% that of long-chain acyl-CoA dehydrogenase activity with its best substrates octanoyl-CoA and dodecanoyl-CoA respectively, activity maximum is shifted to C12 and C14-CoA, enzyme shows an enhanced rate of reoxidation with oxygen
T255E/E376T
-
shifts the chain length activity profile to higher values, drastic reduction of maximal velocity
T92T
-
the mutation is involved in medium chain acyl-CoA dehydrogenase deficiency
T96I
-
the mutation is involved in medium chain acyl-CoA dehydrogenase deficiency
V362V
-
the mutation is involved in medium chain acyl-CoA dehydrogenase deficiency
Y158H
mutation identified in a newborn. Mutatio lowers the temperature threshold at which loss-of-function occurs
Y42H
Y67H
mutation identified in a newborn. Mutatio lowers the temperature threshold at which loss-of-function occurs
K304E
-
maximal velocity of the mutant protein is only one third of the wild-type value. 16% higher activity with the natural electron acceptor, electron transferring flavoprotein, than the wild-type enzyme. Decreased stability at temperatures above 42°C compared to wild-type enzyme
R256K
-
3.6fold increase in Km-value for octanoyl-CoA, 45fold decrease in turnovernumber with octanoyl-CoA compared to wild-type enzyme
Y375K
-
very low acyl-CoA dehydrogenase activity, mutant exhibits acyl-CoA oxidase activity
Y42H
-
mutant enzyme has approximately the same maximal velocity as the wild-type enzyme, the KM-value for octanoyl-CoA is 1.6fold higher than the wild-type value. 7% higher activity with the natural electron acceptor, electron transferring flavoprotein, than the wild-type enzyme. Decreased stability at temperatures above 42°C compared to wild-type enzyme
additional information
A31P
-
the mutation is involved in medium chain acyl-CoA dehydrogenase deficiency
A985G
-
in the Brazilian population, about 0.41% of individuals are heterozygous for the A985G mutation. The mutant homozygous genotype was not found
A985G
-
genotype, the naturally occuring mutation is involved in medium-chain acyl-CoA dehydrogenase deficiency, phenotype, overview
-
the mutation is involved in medium chain acyl-CoA dehydrogenase deficiency
-
mutation slows down the octanoyl-CoA-dependent reductive half-reaction of the enzyme by about 5 orders of magnitude due to impairment in the proton transfer step, also impairs the association and dissociation rates for the binding of the reaction product octenoyl-CoA. Km-value for octanoyl-CoA is 1.6fold reduced, turnover number for octenoyl-CoA is 7083fold reduced compared to wild-type enzyme
-
the mutation is involved in medium chain acyl-CoA dehydrogenase deficiency
-
reported to be responsible for medium-chain CoA dehydrogenase deficiency
K329E
mutation identified in a newborn. Mutatio lowers the temperature threshold at which loss-of-function occurs
-
the mutation is involved in medium chain acyl-CoA dehydrogenase deficiency
-
lipB insertion mutant, zone of growth inhibition around mutant is only ca. 62% of the wild-type inhibition zone indicating a reduced friulimicin production or a modified, less biologically active friulimicin production
additional information
-
AF-toxin I is 55.5% and 97.9% lower in mutant strains 24.1 and 24.1.8, respectively, than in the wild type, AF-toxin II production decreases to almost 70% in strain 24.1 and up to 90% in strain 24.1.8
additional information
-
among 11 Japanese patients with medium-chain acyl-CoA dehydrogenase deficiency, mutation c.449-452delCTGA accounts for 45%. Seven of 10 independent patients carried at least one copy of the mutation. Phenotypes of homozygous patients with the c.449-452delCTGA mutation varied from asymtomatic to life-threatening metabolic decompensations
additional information
-
mutant strain deleted in the pim gene cluster, grows at about half the rate of the wild-type parent when benzoate or pimelate is supplied as the sole carbon source, grows five times more slowly than the wild-type on the C14 dicarboxylic acid tetradecanedioate, but is unimpaired in growth on the C8-fatty acid caprylate